{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T05:22:23Z","timestamp":1773120143173,"version":"3.50.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"DOI":"10.1007\/s11882-026-01262-9","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T04:11:30Z","timestamp":1773029490000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hereditary Alpha-Tryptasemia and Mastocytosis: What We Know and What We Need To Learn"],"prefix":"10.1007","volume":"26","author":[{"given":"Tiago A.","family":"Rama","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1683-8882","authenticated-orcid":false,"given":"Theo","family":"Gulen","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"issue":"1","key":"1262_CR1","first-page":"13","volume":"7","author":"E Crivellato","year":"2003","unstructured":"Crivellato E, Ribatti D, Mallardi F, Beltrami CA. The mast cell: a multifunctional effector cell. Adv Clin Path. 2003;7(1):13\u201326.","journal-title":"Adv Clin Path"},{"issue":"23","key":"1262_CR2","doi-asserted-by":"publisher","first-page":"10743","DOI":"10.7150\/thno.46719","volume":"29","author":"P Valent","year":"2020","unstructured":"Valent P, Akin C, Hartmann K, Nilsson G, Reiter A, Hermine O, et al. Mast cells as a unique hematopoietic lineage and cell system: from Paul Ehrlich\u2019s visions to precision medicine concepts. Theranostics. 2020;29(23):10743\u201368. https:\/\/doi.org\/10.7150\/thno.46719.","journal-title":"Theranostics"},{"issue":"6","key":"1262_CR3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1615\/critrevimmunol.v31.i6.30","volume":"31","author":"AM Gilfillan","year":"2011","unstructured":"Gilfillan AM, Beaven MA. Regulation of mast cell responses in health and disease. Crit Rev Immunol. 2011;31(6):475\u2013529. https:\/\/doi.org\/10.1615\/critrevimmunol.v31.i6.30.","journal-title":"Crit Rev Immunol"},{"issue":"1","key":"1262_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jdermsci.2007.09.009","volume":"49","author":"SJ Galli","year":"2008","unstructured":"Galli SJ, Tsai M. Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. J Dermatol Sci. 2008;49(1):7\u201319. https:\/\/doi.org\/10.1016\/j.jdermsci.2007.09.009.","journal-title":"J Dermatol Sci"},{"key":"1262_CR5","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1146\/annurev.immunol.21.120601.141025","volume":"23","author":"SJ Galli","year":"2005","unstructured":"Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as tunable effector and immunoregulatory cells: recent advances. Annu Rev Immunol. 2005;23:749\u201386. https:\/\/doi.org\/10.1146\/annurev.immunol.21.120601.141025.","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"1262_CR6","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/eji.201040559","volume":"40","author":"SJ Galli","year":"2010","unstructured":"Galli SJ, Tsai M. Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. Eur J Immunol. 2010;40(7):1843\u201351. https:\/\/doi.org\/10.1002\/eji.201040559.","journal-title":"Eur J Immunol"},{"issue":"11","key":"1262_CR7","doi-asserted-by":"publisher","first-page":"5667","DOI":"10.4049\/jimmunol.170.11.5667","volume":"170","author":"LB Schwartz","year":"2003","unstructured":"Schwartz LB, Min HK, Ren S, Xia HZ, Hu J, Zhao W, et al. Tryptase precursors are preferentially and spontaneously released, whereas mature tryptase is retained by HMC-1 cells, Mono-Mac-6 cells, and human skin-derived mast cells. J Immunol. 2003;170(11):5667\u201373.","journal-title":"J Immunol"},{"key":"1262_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000501079","volume":"180","author":"P Valent","year":"2019","unstructured":"Valent P, Bonadonna P, Hartmann K, et al. Why the 20% + 2 tryptase formula is a diagnostic gold standard for severe systemic mast cell activation and mast cell activation syndrome. Int Arch Allergy Immunol. 2019;180:44\u201351.","journal-title":"Int Arch Allergy Immunol"},{"key":"1262_CR9","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.jaci.2021.08.007","volume":"149","author":"A Mateja","year":"2022","unstructured":"Mateja A, Wang Q, Chovanec J, et al. Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis. J Allergy Clin Immunol. 2022;149:1010\u2013e101710.","journal-title":"J Allergy Clin Immunol"},{"key":"1262_CR10","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1016\/j.jaip.2021.06.011","volume":"9","author":"T G\u00fclen","year":"2021","unstructured":"G\u00fclen T, Akin C, Bonadonna P, Siebenhaar F, Broesby-Olsen S, Brockow K, et al. Selecting the right criteria and proper classification to diagnose mast cell activation syndromes: a critical review. J Allergy Clin Immunol Pract. 2021;9:3918\u201328.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1262_CR11","doi-asserted-by":"crossref","unstructured":"Lyons JJ, Schwartz LB. Clinical approach to a patient with elevated serum tryptase: implications of acute versus basally elevated levels. In: Akin C, editor. Mastocytosis. Cham, Switzerland: Springer; 2020. p. 35\u201354.","DOI":"10.1007\/978-3-030-27820-5_3"},{"key":"1262_CR12","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.4049\/jimmunol.138.8.2611","volume":"138","author":"LB Schwartz","year":"1987","unstructured":"Schwartz LB, Irani AM, Roller K, et al. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. J Immunol. 1987;138:2611\u20135.","journal-title":"J Immunol"},{"key":"1262_CR13","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.3390\/diagnostics13213307","volume":"13","author":"T G\u00fclen","year":"2023","unstructured":"G\u00fclen T. A puzzling mast cell trilogy: anaphylaxis, MCAS, and mastocytosis. Diagnostics. 2023;13:3307. https:\/\/doi.org\/10.3390\/diagnostics13213307.","journal-title":"Diagnostics"},{"issue":"12","key":"1262_CR14","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/ng.3696","volume":"48","author":"JJ Lyons","year":"2016","unstructured":"Lyons JJ, Yu X, Hughes JD, Le QT, Jamil A, Bai Y, et al. Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number. Nat Genet. 2016;48(12):1564\u20139.","journal-title":"Nat Genet"},{"issue":"3","key":"1262_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/joim.12410","volume":"279","author":"T Gulen","year":"2016","unstructured":"Gulen T, Hagglund H, Dahlen B, Nilsson G. Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease. J Intern Med. 2016;279(3):211\u201328.","journal-title":"J Intern Med"},{"key":"1262_CR16","doi-asserted-by":"publisher","unstructured":"Valent P, Akin C, Hartmann K, Alvarez-Twose I, Brockow K, Hermine O et al. Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal. Hemasphere. 2021; 13;5(11):e646. https:\/\/doi.org\/10.1097\/HS9.0000000000000646","DOI":"10.1097\/HS9.0000000000000646"},{"issue":"2","key":"1262_CR17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1182\/blood.2020006157","volume":"137","author":"G Greiner","year":"2021","unstructured":"Greiner G, Sprinzl B, G\u00f3rska A, Ratzinger F, Gurbisz M, Witzeneder N, et al. Hereditary \u03b1 tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis. Blood. 2021;137(2):238\u201347.","journal-title":"Blood"},{"issue":"10","key":"1262_CR18","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1016\/j.jaip.2020.05.057","volume":"8","author":"RC Robey","year":"2020","unstructured":"Robey RC, Wilcock A, Bonin H, Beaman G, Myers B, Grattan C, et al. Hereditary Alpha-Tryptasemia: UK Prevalence and Variability in Disease Expression. J Allergy Clin Immunol-Pract. 2020;8(10):3549\u201356. https:\/\/doi.org\/10.1016\/j.jaip.2020.05.057.","journal-title":"J Allergy Clin Immunol-Pract"},{"issue":"2","key":"1262_CR19","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jaci.2021.06.017","volume":"149","author":"MB Chollet","year":"2022","unstructured":"Chollet MB, Akin C. Hereditary alpha tryptasemia is not associated with specific clinical phenotypes. J Allergy Clin Immunol. 2022;149(2):728-735.e2. https:\/\/doi.org\/10.1016\/j.jaci.2021.06.017.","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"1262_CR20","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1182\/bloodadvances.2022007936","volume":"7","author":"J Chovanec","year":"2023","unstructured":"Chovanec J, Tunc I, Hughes J, Halstead J, Mateja A, Liu Y, et al. Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms. Blood Adv. 2023;7(9):1796\u2013810.","journal-title":"Blood Adv"},{"issue":"6","key":"1262_CR21","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1016\/j.jaip.2021.03.005","volume":"9","author":"KT Luskin","year":"2021","unstructured":"Luskin KT, White AA, Lyons JJ. The genetic basis and clinical impact of hereditary alpha-tryptasemia. J Aller Clin Immunol Pract. 2021;9(6):2235\u201342.","journal-title":"J Aller Clin Immunol Pract"},{"key":"1262_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.coi.2021.04.001","volume":"72","author":"JJ Lyons","year":"2021","unstructured":"Lyons JJ, Yi T. Mast cell tryptases in allergic inflammation and immediate hypersensitivity. Curr Opin Immunol. 2021;72:94\u2013106.","journal-title":"Curr Opin Immunol"},{"key":"1262_CR23","doi-asserted-by":"crossref","unstructured":"Gotlib J, Horny HP, Valent P. Mast cells and mastocytosis. In: Hoffman R, Benz JE, editors. Hematology. Basic Principles and Practice. 7th ed. Elsevier; 2018. pp. 1170\u201386.","DOI":"10.1016\/B978-0-323-35762-3.00072-X"},{"issue":"3","key":"1262_CR24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0022-2836(02)00625-3","volume":"321","author":"U Marquardt","year":"2002","unstructured":"Marquardt U, Zettl F, Huber R, Bode W, Sommerhoff C. The crystal structure of human alpha1-tryptase reveals a blocked substrate-binding region. J Mol Biol. 2002;321(3):491\u2013502.","journal-title":"J Mol Biol"},{"issue":"10","key":"1262_CR25","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1084\/jem.20190701","volume":"216","author":"QT Le","year":"2019","unstructured":"Le QT, Lyons JJ, Naranjo AN, Olivera A, Lazarus RA, Metcalfe DD, et al. Impact of naturally forming human alpha\/beta-tryptase heterotetramers in the pathogenesis of hereditary alpha-tryptasemia. J Exp Med. 2019;216(10):2348\u201361.","journal-title":"J Exp Med"},{"issue":"7","key":"1262_CR26","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1056\/NEJMoa1500611","volume":"374","author":"SE Boyden","year":"2016","unstructured":"Boyden SE, Desai A, Cruse G, Young ML, Bolan HC, Scott LM, et al. Vibratory urticaria associated with a missense variant in ADGRE2. N Engl J Med. 2016;374(7):656\u201363.","journal-title":"N Engl J Med"},{"issue":"2","key":"1262_CR27","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.jaci.2020.06.035","volume":"147","author":"JJ Lyons","year":"2021","unstructured":"Lyons JJ, Chovanec J, O\u2019Connell MP, Liu Y, \u0160elb J, Zanotti R, et al. Heritable risk for severe anaphylaxis associated with increased \u03b1-tryptase-encoding germline copy number at TPSAB1. J Allergy Clin Immunol. 2021;147(2):622\u201332.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1262_CR28","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3349\/ymj.2010.51.6.808","volume":"51","author":"SE Lee","year":"2010","unstructured":"Lee SE, Jeong SK, Lee SH. Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis. Yonsei Med J. 2010;51(6):808\u201322.","journal-title":"Yonsei Med J"},{"issue":"8","key":"1262_CR29","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1038\/sj.bjp.0702513","volume":"126","author":"A Kawabata","year":"1999","unstructured":"Kawabata A, Kuroda R, Nishikawa H, Asai T, Kataoka K, Taneda M. Enhancement of vascular permeability by specific activation of protease-activated receptor-1 in rat hindpaw: a protective role of endogenous and exogenous nitric oxide. Br J Pharmacol. 1999;126(8):1856\u201362.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"1262_CR30","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.iac.2018.04.003","volume":"38","author":"JJ Lyons","year":"2018","unstructured":"Lyons JJ. Hereditary alpha tryptasemia: genotyping and associated clinical features. Immunol Allergy Clin North Am. 2018;38(3):483\u201395. https:\/\/doi.org\/10.1016\/j.iac.2018.04.003.","journal-title":"Immunol Allergy Clin North Am"},{"issue":"5","key":"1262_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-021-01010-1","volume":"21","author":"R Wu","year":"2021","unstructured":"Wu R, Lyons JJ. Hereditary alpha-tryptasemia: a commonly inherited modifier of anaphylaxis. Curr Allergy Asthma Rep. 2021;21(5):33.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"1262_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.anai.2025.03.022","volume":"135","author":"M Farley","year":"2025","unstructured":"Farley M, Estrada-Mendizabal RJ, Gansert EA, Voelker D, Marks LA, Gonzalez-Estrada A. Prevalence of mast cell activation disorders and hereditary alpha tryptasemia amongst POTS and EDS patients: a systematic review. Ann Allergy Asthma Immunol. 2025;135(1):97\u2013102. https:\/\/doi.org\/10.1016\/j.anai.2025.03.022.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"1262_CR33","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.anai.2021.08.009","volume":"127","author":"SC Glover","year":"2021","unstructured":"Glover SC, Carter MC, Koro\u0161ec P, Bonadonna P, Schwartz LB, Milner JD, et al. Clinical relevance of inherited genetic differences in human tryptases. Ann Aller Asthma Immunol. 2021;127(6):638\u201347.","journal-title":"Ann Aller Asthma Immunol"},{"issue":"4","key":"1262_CR34","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.anai.2021.12.008","volume":"128","author":"SC Glover","year":"2022","unstructured":"Glover SC, Carlyle A, Lyons JJ. Hereditary alpha-tryptasemia despite normal tryptase-encoding gene copy number owing to copy number loss in trans. Ann Allergy Asthma Immunol. 2022;128(4):460\u20131. https:\/\/doi.org\/10.1016\/j.anai.2021.12.008.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1262_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13246380","volume":"13","author":"R Zanotti","year":"2021","unstructured":"Zanotti R, Bonifacio M, Isolan C, Tanasi I, Crosera L, Olivieri F, et al. A multidisciplinary diagnostic approach reveals a higher prevalence of indolent systemic mastocytosis: 15-years\u2019 experience of the GISM network. Cancers. 2021;13:6380. https:\/\/doi.org\/10.3390\/cancers13246380.","journal-title":"Cancers"},{"issue":"16","key":"1262_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14163942","volume":"14","author":"J Ungerstedt","year":"2022","unstructured":"Ungerstedt J, Ljung C, Klimkowska M, G\u00fclen T. Clinical outcomes of adults with systemic mastocytosis: a 15-year multidisciplinary experience. Cancers (Basel). 2022;14(16):3942. https:\/\/doi.org\/10.3390\/cancers14163942.","journal-title":"Cancers (Basel)"},{"issue":"12","key":"1262_CR37","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1016\/j.jaip.2024.08.044","volume":"12","author":"P Valent","year":"2024","unstructured":"Valent P, Hartmann K, Hoermann G, Reiter A, Alvarez-Twose I, Brockow K, et al. Harmonization of diagnostic criteria in mastocytosis for use in clinical practice: WHO vs ICC vs AIM\/ECNM. J Allergy Clin Immunol Pract. 2024;12(12):3250-3260.e5. https:\/\/doi.org\/10.1016\/j.jaip.2024.08.044.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"1262_CR38","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1182\/blood-2006-06-028100","volume":"110","author":"C Akin","year":"2007","unstructured":"Akin C, Scott LM, Kocabas CN, Kushnir-Sukhov N, Brittain E, Noel P, Metcalfe DD. Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with idiopathic anaphylaxis. Blood. 2007;110(7):2331\u20133. https:\/\/doi.org\/10.1182\/blood-2006-06-028100.","journal-title":"Blood"},{"issue":"9","key":"1262_CR39","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/cea.12369","volume":"44","author":"T G\u00fclen","year":"2014","unstructured":"G\u00fclen T, H\u00e4gglund H, Sander B, Dahl\u00e9n B, Nilsson G. The presence of mast cell clonality in patients with unexplained anaphylaxis. Clin Exp Allergy. 2014;44(9):1179\u201387. https:\/\/doi.org\/10.1111\/cea.12369.","journal-title":"Clin Exp Allergy"},{"issue":"8","key":"1262_CR40","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.jaip.2022.05.007","volume":"10","author":"P Valent","year":"2022","unstructured":"Valent P, Hartmann K, Bonadonna P, G\u00fclen T, Brockow K, Alvarez-Twose I, et al. Global classification of mast cell activation disorders: an ICD-10-CM-adjusted proposal of the ECNM-AIM consortium. The Journal of Allergy and Clinical Immunology: In Practice. 2022;10(8):1941\u201350. https:\/\/doi.org\/10.1016\/j.jaip.2022.05.007.","journal-title":"The Journal of Allergy and Clinical Immunology: In Practice"},{"issue":"1","key":"1262_CR41","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jaci.2017.05.036","volume":"141","author":"MC Carter","year":"2018","unstructured":"Carter MC, Desai A, Komarow HD, Bai Y, Clayton ST, Clark AS, et al. A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis. J Allergy Clin Immunol. 2018;141(1):180-188.e3. https:\/\/doi.org\/10.1016\/j.jaci.2017.05.036.","journal-title":"J Allergy Clin Immunol"},{"key":"1262_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.103043","volume":"80","author":"T Ballul","year":"2025","unstructured":"Ballul T, Sabato V, Valent P, Hermine O, Lortholary O, Rossignol J, et al. Characterization of patients with clonal mast cells in the bone marrow with clinical significance not otherwise specified. EClinicalMedicine. 2025;80:103043. https:\/\/doi.org\/10.1016\/j.eclinm.2024.103043.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"1262_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-025-00611-8","volume":"11","author":"C Akin","year":"2025","unstructured":"Akin C, Arock M, Carter MC, George TI, Valent P. Mastocytosis. Nat Rev Dis Primers. 2025;11(1):30. https:\/\/doi.org\/10.1038\/s41572-025-00611-8.","journal-title":"Nat Rev Dis Primers"},{"key":"1262_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/cea.12225","volume":"44","author":"T G\u00fclen","year":"2014","unstructured":"G\u00fclen T, Hagglund H, Dahlen B, Nilsson G. High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience. Clin Exp Allergy. 2014;44:121\u20139.","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"1262_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.iac.2021.09.007","volume":"42","author":"T G\u00fclen","year":"2022","unstructured":"G\u00fclen T, Akin C. Anaphylaxis and mast cell disorders. Immunol Allergy Clin North Am. 2022;42(1):45\u201363. https:\/\/doi.org\/10.1016\/j.iac.2021.09.007.","journal-title":"Immunol Allergy Clin North Am"},{"key":"1262_CR46","doi-asserted-by":"publisher","unstructured":"Alvarez-Twose I, Gonz\u00e1lez de Olano D, S\u00e1nchez-Mu\u00f1oz L, Matito A, Esteban-L\u00f3pez MI, Vega A et al. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms. J Allergy Clin Immunol. 2010;125(6):1269\u20131278.e2. https:\/\/doi.org\/10.1016\/j.jaci.2010.02.019. PMID: 20434205.","DOI":"10.1016\/j.jaci.2010.02.019"},{"issue":"5","key":"1262_CR47","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.jaip.2017.02.008","volume":"5","author":"T G\u00fclen","year":"2017","unstructured":"G\u00fclen T, Ljung C, Nilsson G, Akin C. Risk factor analysis of anaphylactic reactions in patients with systemic mastocytosis. J Allergy Clin Immunol Pract. 2017;5(5):1248\u201355. https:\/\/doi.org\/10.1016\/j.jaip.2017.02.008.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"1262_CR48","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/j.1398-9995.2012.02812.x","volume":"67","author":"I Alvarez-Twose","year":"2012","unstructured":"Alvarez-Twose I, Vano-Galvan S, Sanchez-Munoz L, Morgado JM, Matito A, Torrelo A, et al. Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis. Allergy. 2012;67(6):813\u201321.","journal-title":"Allergy"},{"key":"1262_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052684","author":"K Brockow","year":"2021","unstructured":"Brockow K, Plata-Nazar K, Lange M, Nedoszytko B, Niedoszytko M, Valent P. Mediator-related symptoms and anaphylaxis in children with mastocytosis. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22052684.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1262_CR50","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1111\/all.12013","volume":"67","author":"K Brockow","year":"2012","unstructured":"Brockow K, Ring J, Alvarez-Twose I, Orfao A, Escribano L. Extensive blistering is a predictor for severe complications in children with mastocytosis. Allergy. 2012;67(10):1323\u20134.","journal-title":"Allergy"},{"issue":"2","key":"1262_CR51","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jaip.2024.10.039","volume":"13","author":"RN Kaakati","year":"2025","unstructured":"Kaakati RN, Khokhar D, Akin C. Demographics, types of patient-reported allergic diseases, and anaphylaxis in mastocytosis: a single-center US experience. J Allergy Clin Immunol Pract. 2025;13(2):398\u2013406. https:\/\/doi.org\/10.1016\/j.jaip.2024.10.039.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1262_CR52","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1111\/all.16132","volume":"79","author":"M Niedoszytko","year":"2024","unstructured":"Niedoszytko M, Gorska A, Brockow K, Bonadonna P, Lange M, Kluin-Nelemans H, et al. Prevalence of hypersensitivity reactions in various forms of mastocytosis: a pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry. Allergy. 2024;79:2470\u201381.","journal-title":"Allergy"},{"issue":"3","key":"1262_CR53","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jaci.2008.11.018","volume":"123","author":"P Bonadonna","year":"2009","unstructured":"Bonadonna P, Perbellini O, Passalacqua G, Caruso B, Colarossi S, Dal Fior D, et al. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol. 2009;123(3):680\u20136. https:\/\/doi.org\/10.1016\/j.jaci.2008.11.018.","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"1262_CR54","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1016\/j.jaip.2020.05.044","volume":"8","author":"J Jarkvist","year":"2020","unstructured":"Jarkvist J, Brockow K, G\u00fclen T. Low frequency of IgE-mediated food hypersensitivity in mastocytosis. J Allergy Clin Immunol Pract. 2020;8(9):3093\u2013101. https:\/\/doi.org\/10.1016\/j.jaip.2020.05.044.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"1262_CR55","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/j.jaip.2024.03.040","volume":"12","author":"M Beyens","year":"2024","unstructured":"Beyens M, Sabato V, Ebo DG, Zaghmout T, G\u00fclen T. Drug-induced anaphylaxis uncommon in mastocytosis: findings from two large cohorts. The Journal of Allergy and Clinical Immunology: In Practice. 2024;12(7):1850-1862.e1. https:\/\/doi.org\/10.1016\/j.jaip.2024.03.040.","journal-title":"The Journal of Allergy and Clinical Immunology: In Practice"},{"issue":"10","key":"1262_CR56","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1111\/all.13445","volume":"73","author":"MAW Hermans","year":"2018","unstructured":"Hermans MAW, van der Vet SQA, van Hagen PM, van Wijk RG, van Daele PLA. Low frequency of acetyl salicylic acid hypersensitivity in mastocytosis: the results of a double-blind, placebo-controlled challenge study. Allergy. 2018;73(10):2055\u201362. https:\/\/doi.org\/10.1111\/all.13445.","journal-title":"Allergy"},{"issue":"3","key":"1262_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/clt2.12132","volume":"12","author":"TA Rama","year":"2022","unstructured":"Rama TA, Morgado JM, Henriques A, Escribano L, Alvarez-Twose I, Sanchez-Mu\u00f1oz L, et al. Mastocytosis presenting with mast cell-mediator release-associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features. Clin Transl Allergy. 2022;12(3):e12132. https:\/\/doi.org\/10.1002\/clt2.12132.","journal-title":"Clin Transl Allergy"},{"issue":"5","key":"1262_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/falgy.2022.1071807","volume":"3","author":"P Bonadonna","year":"2022","unstructured":"Bonadonna P, Olivieri F, Jarkvist J, Nalin F, Zanotti R, Maclachlan L, et al. Non-steroidal anti-inflammatory drug-induced anaphylaxis infrequent in 388 patients with mastocytosis: a two-center retrospective cohort study. Front Allergy. 2022;3(5):1071807. https:\/\/doi.org\/10.3389\/falgy.2022.1071807.","journal-title":"Front Allergy"},{"issue":"30","key":"1262_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13132241","volume":"13","author":"J Jarkvist","year":"2023","unstructured":"Jarkvist J, G\u00fclen T. Diagnostic evaluation of hypersensitivity reactions to antibiotics in a large cohort of mastocytosis patients. Diagnostics (Basel). 2023;13(30):2241. https:\/\/doi.org\/10.3390\/diagnostics13132241.","journal-title":"Diagnostics (Basel)"},{"key":"1262_CR60","doi-asserted-by":"publisher","unstructured":"Polivka L, Madrange M, Bulai-Livideanu C, Barete S, Ballul T, Neuraz A, et al. Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes. J Allergy Clin Immunol. 2024;153(1):349-353.e4. https:\/\/doi.org\/10.1016\/j.jaci.2023.08.015.","DOI":"10.1016\/j.jaci.2023.08.015"},{"issue":"2","key":"1262_CR61","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jaci.2022.09.038","volume":"151","author":"B Sordi","year":"2023","unstructured":"Sordi B, Vanderwert F, Crupi F, Gesullo F, Zanotti R, Bonadonna P, et al. Disease correlates and clinical relevance of hereditary \u03b1-tryptasemia in patients with systemic mastocytosis. J Allergy Clin Immunol. 2023;151(2):485-493.e11. https:\/\/doi.org\/10.1016\/j.jaci.2022.09.038.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1262_CR62","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/all.15911","volume":"79","author":"D Gonz\u00e1lez-de-Olano","year":"2024","unstructured":"Gonz\u00e1lez-de-Olano D, Navarro-Navarro P, Mu\u00f1oz-Gonz\u00e1lez JI, S\u00e1nchez-Mu\u00f1oz L, Henriques A, de-Andr\u00e9s-Mart\u00edn A, et al. Clinical impact of the TPSAB1 genotype in mast cell diseases: a REMA study in a cohort of 959 individuals. Allergy. 2024;79(3):711\u201323. https:\/\/doi.org\/10.1111\/all.15911.","journal-title":"Allergy"},{"issue":"9","key":"1262_CR63","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1111\/all.16084","volume":"79","author":"P Korosec","year":"2024","unstructured":"Korosec P, Sturm GJ, Lyons JJ, Marolt TP, Svetina M, Kosnik M, et al. High burden of clonal mast cell disorders and hereditary alpha-tryptasemia in patients who need Hymenoptera venom immunotherapy. Allergy. 2024;79(9):2458\u201369. https:\/\/doi.org\/10.1111\/all.16084.","journal-title":"Allergy"},{"issue":"5","key":"1262_CR64","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1111\/all.15584","volume":"78","author":"P Navarro-Navarro","year":"2023","unstructured":"Navarro-Navarro P, Alvarez-Twose I, Perez-Pons A, Henriques A, Mayado A, Garcia-Montero AC, et al. KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes. Allergy. 2023;78(5):1347\u201359. https:\/\/doi.org\/10.1111\/all.15584.","journal-title":"Allergy"},{"issue":"3","key":"1262_CR65","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jaip.2022.11.042","volume":"11","author":"TA Rama","year":"2023","unstructured":"Rama TA, Torrado I, Henriques AF, Sanchez-Munoz L, Jara-Acevedo M, Navarro-Navarro P, et al. Mast Cell Activation Syndromes: Comparison Between Two Scoring Models to Predict for Mast Cell Clonality. J Allergy Clin Immunol Pract. 2023;11(3):908\u201319. https:\/\/doi.org\/10.1016\/j.jaip.2022.11.042. e4.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1262_CR66","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025029507","author":"P Navarro-Navarro","year":"2025","unstructured":"Navarro-Navarro P, Gonz\u00e1lez-Tablas M, P\u00e9rez-Pons A, S\u00e1nchez-Mu\u00f1oz L, Henriques A, \u00c1lvarez-Twose I, et al. Improved diagnostic screening and classification of clonal mast cell diseases by ultrasensitive KIT p.D816V detection. Blood. 2025. https:\/\/doi.org\/10.1182\/blood.2025029507.","journal-title":"Blood"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-026-01262-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-026-01262-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-026-01262-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:02:56Z","timestamp":1773075776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-026-01262-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1262"],"URL":"https:\/\/doi.org\/10.1007\/s11882-026-01262-9","relation":{},"ISSN":["1534-6315"],"issn-type":[{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"25 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Rama has received consultancy from Blueprint Medicines, Alfasigma, and lecture fees from Novartis and ThermoFisher. Dr. G\u00fclen has received lecture fees from ALK.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"19"}}